ITACTA WEBINAR – ON-DEMAND
The webinar entitled “Endotoxemia and role of Polymyxin B hemoperfusion in the cardiovascular intensive care unit” held in collaboration with ITACTA (Italian Association of Cardiothoracic Anaesthesiologists)is now available ON-DEMAND. This webinar aims to describe and discuss the pathogenic action of endotoxemia in various clinical contests of patients hospitalized in a cardiovascular intensive care unit and the role of Polymyxin B hemoperfusion as possible therapeutic option in adult and pediatric patients.
ITACTA WEBINAR
On April 15th, 2021, at 5pm (CEST), in collaboration with ITACTA (Italian Association of Cardiothoracic Anaesthesiologists) Estor is supporting an Italian language webinar entitled: “Endotoxemia and role of Polymyxin B hemoperfusion in the cardiovascular intensive care unit”.
This webinar aims to describe and discuss the pathogenic action of endotoxemia in various clinical contests of patients hospitalized in a cardiovascular intensive care unit and the role of Polymyxin B hemoperfusion as possible therapeutic option in adult and pediatric patients.
Reduction of complement activation and renal dysfunction with PMMA-based CVVH treatment in sepsis-induced AKI
New relevant findings on the role of polymethylmethacrylate (PMMA)-based CVVH in an animal model of sepsis-induced AKI have been published in Frontiers in Immunology. The results show that PMMA-based CVVH significantly reduces tissue and systemic complement activation limiting renal damage and fibrosis highlighting the potential role of PMMA membrane as a therapeutic strategy in patients with septic acute kidney injury (AKI).
A “small” big revolution in blood purification therapies for sepsis: TORAYMYXIN® PMX-05R
We are proud to launch Toraymyxin® PMX-05R, Polymyxin B hemoperfusion therapy medical device specifically designed for the management of un-responsive septic shock in patients with reduced body volume. The reduced size PMX-05R device is the ideal choice for smaller body volume patients guaranteeing the unique properties and performances of Polymyxin B hemoperfusion, maintaining the high quality standards of TORAY and fully responding to global clinical needs.
Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients Requiring Noradrenaline
Results from the Nationwide Administrative Database in Japan concerning adults diagnosed with septic shock and requiring noradrenaline support during the period 2016-2019 have been published in the Blood Purification journal by Fujimori and co-workers.
COVID-19 and Polymyxin B Hemoperfusion – Data from the EUPHAS-2 registry
Polymyxin B hemoperfusion experience from critically ill COVID-19 patients with endotoxic shock has been published recently in Artificial Organs. The study refers to 12 COVID-19 patients hospitalized in ICU who developed a secondary infection – endotexemia leading to septic shock status and whose data were collected in the observational study EUPHAS 2 from February to May 2020, showing very interesting results.